Popular Filters
Phase 3 Trials
PD-L1 Inhibitor
Rilvegostomig + Pembrolizumab + Chemotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Phoenix, Arizona
"This trial is comparing the effectiveness and safety of rilvegostomig with pembrolizumab, when used alongside platinum-based chemotherapy, for treating patients with a specific type of lung cancer
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist
Rimegepant for Migraine
Recruiting1 awardPhase 3
Springfield, Missouri
This trial is studying the effects of a medication called rimegepant on teenagers who suffer from frequent migraine attacks. Participants will take either the rimegepant tablet or an inactive tablet every
Trials With No Placebo
Sequence 3 = CDBEAF for Tobacco Use
Recruiting1 award10 criteria
Bentonville, Arkansas
The purpose of this study was to obtain information on nicotine exposure following the use of five oral tobacco-derived nicotine (OTDN) products relative to subjects' own brand moist smokeless tobacco (OBMST) product in adult moist smokeless tobacco (MST) users, as well as to characterize subjective effects under controlled use conditions. Male and female adult MST users between the ages of 22 to 65 years were recruited. The total duration of participation for each subject was approximately 34 days including screening and a 6-day in-clinic study confinement period.
Behavioural Intervention
Electrical Muscle Stimulation Exercise for Muscle Loss
Recruiting1 award3 criteria
Columbia, Missouri
This trial will test the effects of a type of exercise called whole-body electrical muscle stimulation (WB-EMS Exercise) on muscle activation in healthy adults. The study will also see if this exercise can improve
Trials Offering Remuneration
CGRP Receptor Antagonist
Zavegepant for Healthy Breastfeeding Women
Recruiting1 awardPhase 1
Springfield, Missouri
"This trial aims to study the levels of zavegepant in breast milk after administering a single dose through the nose to healthy breastfeeding women. The goal is to determine if there are any potential risks
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.